Framingham, MA, United States of America

Daniel Griffith Anderson

USPTO Granted Patents = 117 

 

 

Average Co-Inventor Count = 4.8

ph-index = 18

Forward Citations = 1,854(Granted Patents)


Inventors with similar research interests:


Location History:

  • San Angelo, TX (US) (2014 - 2017)
  • Sudbiry, MA (US) (2018)
  • Sudbury, MA (US) (2010 - 2020)
  • Farmingham, MA (US) (2020)
  • Framington, MA (US) (2020)
  • Framingham, MA (US) (2006 - 2024)
  • Cambridge, MA (US) (2017 - 2024)

Company Filing History:

goldMedal98 out of 8,369 
 
Massachusetts Institute of Technology
 patents
silverMedal23 out of 1,036 
 
Children's Medical Center Corporation
 patents
bronzeMedal13 out of 48 
 
Living Proof, Inc.
 patents
44 out of 153 
 
Translate Bio, Inc.
 patents
52 out of 11 
 
Orna Therapeutics, Inc.
 patents
62 out of 303 
 
Whitehead Institute for Biomedical Research
 patents
71 out of 16,070 
 
USA As Represented by Secretary of the Navy
 patents
81 out of 86 
 
Shire Human Genetic Therapies, Inc.
 patents
91 out of 1 
 
Wilbur L. Anderson, Inc.
 patent
101 out of 36 
 
Performance Indicator, LLC
 patents
111 out of 2 
 
Children's Medical Center Coporation
 patents
121 out of 196 
 
Politecnico Di Milano
 patents
131 out of 100 
 
The University of Nottingham
 patents
141 out of 2,882 
 
The General Hospital Corporation
 patents
151 out of 87 
 
Seattle Children's Hospital
 patents
161 out of 1,370 
 
The Brigham and Women's Hospital, Inc.
 patents
172 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
117 patents (USPTO):

Daniel Griffith Anderson: A Leading Innovator in Polymer-Lipids and Compositions

Meet Daniel Griffith Anderson, a renowned inventor and researcher in the field of polymer-lipids and compositions, hailing from Framingham, MA. Anderson has made significant contributions to the field of medical science through his remarkable work in the development of innovative technologies and patents for the delivery of therapeutic agents such as nucleic acids to the target cells.

Anderson's illustrious career has spanned several years, having worked with renowned organizations like Massachusetts Institute of Technology and Children's Medical Center Corporation. He has set an exemplary record in the number of patents he has obtained, which is a whopping 94 patents.

Recently, Anderson has made significant strides in improving the selection and formulation of PBAE polymers. In one of his latest patents, Anderson has developed a design of experiment approach, which uses statistical methods for limiting the possible experimental conditions. This method has proved to be a game-changer and has led to the development of improved PBAE polymers and formulations that offer better drug-delivery features.

Additionally, Anderson's patent in poly (beta-amino esters) and uses thereof has gained a lot of attention. The branched poly (beta-amino esters) (PBAE) is useful as a delivery vehicle for therapeutic agents and has shown promising results in delivering therapeutic agents such as mRNA to lung epithelial cells.

Anderson has worked with exceptional co-workers like Robert S Langer and Arturo Jose Vegas, who are well-known in the field of medical science for their groundbreaking research and contributions.

In conclusion, Daniel Griffith Anderson's contributions to the field of polymer-lipids and compositions have been immense. His inventions have impacted the field of drug delivery and have the potential to revolutionize the healthcare industry. With continued research and development, Anderson and his team may just be uncovering the tip of the iceberg with the potential applications of their patents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…